Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shun Ukai
Observed name:
S. Ukai
Institution:
Toyohashi Municipal Hospital
Observed institutions:
Chiba University,
Konan Kosei Hospital,
Chiba University Hospital,
Kiadis Pharma (Netherlands),
Toyohashi Municipal Hospital,
Nagoya University
show all 6
OpenAlex ID:
A5011178861
Connective tissue growth factor and β‐catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma
2014
·
Li Jiang
, Yoriko Yamashita
, et al.
·
The Journal of Pathology
·
36
Impact of a Nutritional Risk Index on Clinical Outcomes after Allogeneic Hematopoietic Cell Transplantation
2019
·
Ken Sagou
, Kazutaka Ozeki
, et al.
·
Transplantation and Cellular Therapy
·
25
PDF
Patterns of onset and outcome of cryptogenic organizing pneumonia after allogeneic hematopoietic stem cell transplantation
2019
·
Yoshitaka Adachi
, Kazutaka Ozeki
, et al.
·
International Journal of Hematology
·
15
Optimal dosage of methotrexate for GVHD prophylaxis in umbilical cord blood transplantation
2019
·
Yoshitaka Adachi
, Kazutaka Ozeki
, et al.
·
International Journal of Hematology
·
12
Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm arising from myelodysplastic/myeloproliferative neoplasms
2020
·
Ken Sagou
, Makoto Ito
, et al.
·
Clinical Case Reports
·
6
Intrapatient variability in concentration/dose ratio of tacrolimus predicts transplant-associated thrombotic microangiopathy
2020
·
Ken Sagou
, Nobuaki Fukushima
, et al.
·
International Journal of Hematology
·
5
Clinical usefulness of diagnostic criteria for transplant-associated thrombotic microangiopathy
2020
·
Ken Sagou
, Nobuaki Fukushima
, et al.
·
International Journal of Hematology
·
5
Promising Outcome of Umbilical Cord Blood Transplantation in Patients with Multiple Comorbidities
2018
·
Yoshitaka Adachi
, Shun Ukai
, et al.
·
Transplantation and Cellular Therapy
·
5
Permanent Impairment-Free, Relapse-Free Survival: A Novel Composite Endpoint to Evaluate Long-Term Success in Allogeneic Transplantation
2020
·
Yoshitaka Adachi
, Kazutaka Ozeki
, et al.
·
Transplantation and Cellular Therapy
·
2
Decline of forced expiratory volume in 1 s after allogeneic hematopoietic cell transplantation is a good indicator for pulmonary damage and is associated with busulfan use
2019
·
Ken Sagou
, Shun Ukai
, et al.
·
International Journal of Hematology
·
2
Severe Multiorgan Failure Associated with Differentiation Syndrome in a High-risk Acute Promyelocytic Leukemia Patient with Concurrent Influenza A
2026
·
Sunami Yoshimoto
, Naoto Imoto
, et al.
·
Internal Medicine
PDF
Prognostic impact of WT1 dynamics in peripheral blood before and after allogeneic HSCT in patients with AML and MDS
2026
·
Tomoyoshi Wakayama
, Naoto Imoto
, et al.
·
International Journal of Hematology
Bridging therapy by azacitidine in a patient with atypical chronic myeloid leukemia, followed by human leukocyte antigen- haploidentical stem cell transplantation
2021
·
Miyo Goto
, Nobuaki Fukushima
, et al.
·
Japanese Journal of Transplantation and Cellular Therapy
PDF
Pf768 the Intrapatient Variability of Blood Level of Tacrolimus Predicts Transplant‐associated Thrombotic Microangiopathy
2019
·
K. Sagou
, S. Ukai
, et al.
·
HemaSphere
Pf754 Permanent Impairment‐free, Relapse‐free Survival: a Novel Composite Endpoint to Evaluate Long‐term Success in Allogeneic Stem Cell Transplantation
2019
·
Y. Adachi
, K. Ozeki
, et al.
·
HemaSphere
The Optimal Dosage of Methotrexate for Graft-Versus-Host Disease Prophylaxis in Umbilical Cord Blood Transplantation
2019
·
Yoshitaka Adachi
, Kazutaka Ozeki
, et al.
·
Transplantation and Cellular Therapy
Show more works
View as search
Works count:
16
Citation count:
113
H-index:
5
I10-index:
4
Year
Topic
Type